GlobeNewswire (press release) The company also intends to use its series of proprietary lead compounds from its novel macrolide library for uses such as the treatment of chronic inflammatory diseases, endocrine diseases and gastric motility disorders. Additional information about ... and more »
Marketwire (Communiqué de presse) PYLERA est le seul traitement de marque disponible qui ne contient pas de clarithromycine, un antibiotique macrolide . L'utilisation des antibiotiques macrolides contribuerait à l'augmentation croissante des souches de bactéries H. pylori résistantes à ...
Medscape Macrolide antibiotics and "ruby red grapefruit juice in the amount of ¼ liter" are CYP3A4 inhibitors, so don't mix either with fibrates. There is a 1.5 times increase in muscle toxicity when fibrates are mixed with lovastatin. Case study: a 77-year old ...
Marketwire (press release) PYLERA is the only branded treatment option available that does not contain clarithromycin, a macrolide antibiotic. Utilization of macrolide antibiotics are believed to contribute to the growing rate of clarithromycin-resistant H. pylori. With the 10 ... and more »
